Related Experiment Video
Updated: Jul 2, 2026

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
Published on: October 10, 2025
TNF-alpha/IL-1/NF-kappaB transduction pathway in human cancer prostate
M Royuela1, G Rodríguez-Berriguete, B Fraile
1Department of Cell Biology and Genetics, University of Alcalá, Alcalá de Henares, Madrid, Spain. mar.royuela@uah.es
Tumor necrosis factor-alpha (TNFalpha) and interleukin-1 (IL-1) signaling pathways promote prostate cancer proliferation. Inhibiting these pro-inflammatory cytokines may offer a novel therapeutic strategy for prostate cancer (PC).
Area of Science:
- Molecular Biology
- Cell Signaling
- Oncology
Background:
- Tumor necrosis factor-alpha (TNFalpha) and interleukin-1 (IL-1) are key cytokines involved in cellular processes.
- These cytokines activate complex intracellular signal transduction pathways.
- Dysregulation of these pathways is implicated in cancer development and progression.
Purpose of the Study:
- To investigate the TNFalpha/IL-1 signal transduction pathway components in human prostate carcinoma (PC) versus normal prostate tissue.
- To identify potential therapeutic targets for prostate cancer treatment within these pathways.
Main Methods:
- Comparative analysis of TNFalpha/IL-1 pathway components in PC and normal prostate samples.
- Evaluation of key kinase proteins (TRAF-2, ASK1, MEK-4, JNK, p38) and transcription factors (AP-1, NF-kappaB, Elk-1, ATF-2).
Main Results:
- The pro-apoptotic TNFalpha/AP-1 pathway appears inactivated in prostate cancer, potentially due to p21 and bcl-2.
- Prostate cancer cells exhibit diversion towards p38 or NIK activation, promoting proliferation.
- IL-1 signaling enhances proliferation by activating NIK or p38, leading to transcription factor activation.
Conclusions:
- The TNFalpha and IL-1 signaling pathways are significantly altered in prostate cancer, favoring proliferation over apoptosis.
- Targeting pro-inflammatory cytokines like IL-1 and TNFalpha could be a viable therapeutic strategy for PC.
- Inhibition may decrease the activity of key transcription factors (NF-kappaB, Elk-1, ATF-2) driving cancer cell growth.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Abnormal Proliferation
The Ras Gene
Ras is a superfamily...